Back
Innoviva, Inc. 10K Form
Buy
64
INVA
Innoviva, Inc.
Last Price:
$23.02
Seasonality Move:
3.64%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive INVA News And Ratings
See the #1 stock for the next 7 days that we like better than INVA
INVA Financial Statistics
Sales & Book Value
| Annual Sales: | $425.1M |
|---|---|
| Cash Flow: | $54.5M |
| Price / Cash Flow: | 9.16 |
| Annual Sales: | $15.71 |
| Price / Book: | 1.43 |
Profitability
| EPS (TTM): | 3.05530 |
|---|---|
| Net Income (TTM): | $271.2M |
| Gross Margin: | $307.5M |
| Return on Equity: | 32.01% |
| Return on Assets: | 19.4% |
Innoviva, Inc. Earnings Forecast
Key Innoviva, Inc. Financial Ratios
-
The Gross Profit Margin over the past 26 years for INVA is 72.33%.
-
The Selling, General & Administrative Expenses for INVA have been equal to 26.66% of Gross Profit Margin.
-
The Research & Development expenses have been 7.20% of Revenue.
-
The Interest Expense is 6.16% of Operating Income.
-
The Net Earning history of INVA is 63.78% of Total Revenues.
-
Per Share Earnings over the last 26 years have been positive in 16 years.
Innoviva, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | INVA |
| CUSIP: | 45781M |
| Website: | inva.com |
Debt
| Debt-to-Equity Ratio: | 0.23 |
|---|---|
| Current Ratio: | 14.64 |
| Quick Ratio: | 13.28 |
Price-to-Earnings
| Trailing P/E Ratio: | 6.85 |
|---|---|
| Forward P/E Ratio: | 10.23 |
INVA Technical Analysis vs Fundamental Analysis
Buy
64
Innoviva, Inc. (INVA)
is a Buy
Is Innoviva, Inc. a Buy or a Sell?
-
Innoviva, Inc. stock is rated a BuyThe current Innoviva, Inc. [INVA] share price is $22.99. The Score for INVA is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.